NCT04002895View on ClinicalTrials.gov

What the Body Does to Foliglurax in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

August 8, 2019

Conditions
Healthy
Interventions
DRUG

Foliglurax

Single oral dose of 80 mg \[14C\]-foliglurax(93µCi/3.44 MBq), 1mg/mL oral solution (prepared from \[14C\]-foliglurax powder for oral solution)

Trial Locations (1)

Unknown

GB1050 Covance, Leeds

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04002895 - What the Body Does to Foliglurax in Healthy Volunteers | Biotech Hunter | Biotech Hunter